Table 2.
β coefficient (95% CI) | p value | |
---|---|---|
C–C motif chemokine 15 | − 0.53 (− 0.71 to − 0.35) | < 0.001 |
Complement component C1q receptor | − 0.14 (− 0.20 to − 0.09) | < 0.001 |
Perlecan | − 0.05 (− 0.07 to − 0.03) | < 0.001 |
Bleomycin hydrolase | − 0.22 (− 0.34 to − 0.11) | < 0.001 |
CD166 antigen | − 0.15 (− 0.23 to − 0.07) | < 0.001 |
SLAM family member 5 | − 0.13 (− 0.22 to − 0.05) | 0.002 |
Fibroblast growth factor 23 | 0.63 (0.23–1.04) | 0.002 |
Associations of baseline free form indoxyl sulfate with selected protein biomarker NPX value using multivariate linear regression model adjusting for age, sex, hemodialysis duration, cause of end-stage renal disease, arteriovenous shunt type, comorbidities (diabetes mellitus, hypertension, and dyslipidemia), medications (antiplatelet/warfarin, anti-hypertensive drugs, diabetic treatment drugs), and laboratory data (calcium, phosphate, high sensitivity C-reactive protein, and Kt/V).